Naia Limited Appoints Three World-Class Business And Healthcare Thought Leaders To Its Business Advisory Board

GREENBRAE, Calif.--(BUSINESS WIRE)--Naia Limited, an international drug development company with an initial portfolio of innovative, clinical stage compounds for short bowel syndrome, NASH and Type 2 diabetes, today announced three additions to its business advisory board. The new members are Edmund Pezalla, M.D., MPH, vice president and national medical director for pharmaceutical policy and strategy at Aetna, Hoyoung Huh, M.D., Ph.D., chairman of the board of directors of Geron Corporation and Cytomx Therapeutics, Inc., and Lord Edward (Tim) Razzall, Commander of the Order of the British Empire (CBE), partner at RT Associates, and leading member of the Liberal-Democratic Party (U.K.).

Help employers find you! Check out all the jobs and post your resume.